Pro- and Anti- Effects of Immunoglobulin A- Producing B Cell in Tumors and Its Triggers

B cells are well known as key mediators of humoral immune responses via the production of antibodies. Immunoglobulin A (IgA) is the most abundantly produced antibody isotype and provides the first line of immune protection at mucosal surfaces. However, IgA has long been a divisive molecule with resp...

Full description

Bibliographic Details
Main Authors: Ziwen Zhong, Ke Nan, Meilin Weng, Ying Yue, Wenchang Zhou, Zhiqiang Wang, Yiwei Chu, Ronghua Liu, Changhong Miao
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.765044/full
_version_ 1818990485626159104
author Ziwen Zhong
Ziwen Zhong
Ke Nan
Meilin Weng
Ying Yue
Wenchang Zhou
Zhiqiang Wang
Yiwei Chu
Yiwei Chu
Ronghua Liu
Changhong Miao
author_facet Ziwen Zhong
Ziwen Zhong
Ke Nan
Meilin Weng
Ying Yue
Wenchang Zhou
Zhiqiang Wang
Yiwei Chu
Yiwei Chu
Ronghua Liu
Changhong Miao
author_sort Ziwen Zhong
collection DOAJ
description B cells are well known as key mediators of humoral immune responses via the production of antibodies. Immunoglobulin A (IgA) is the most abundantly produced antibody isotype and provides the first line of immune protection at mucosal surfaces. However, IgA has long been a divisive molecule with respect to tumor progression. IgA exerts anti- or pro-tumor effect in different tumor types. In this review, we summarize emerging evidence regarding the production and effects of IgA and IgA+ cells in the tumor microenvironment (TME). Moreover, we discuss that the TME cytokines, host diet, microbiome, and metabolites play a pivotal role in controlling the class-switch recombination (CSR) of IgA. The analysis of intratumoral Ig repertoires and determination of metabolites that influence CSR may help establish novel therapeutic targets for the treatment of cancers.
first_indexed 2024-12-20T19:55:07Z
format Article
id doaj.art-849ea2bc75c440928c6a1581b0e8b6b3
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-20T19:55:07Z
publishDate 2021-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-849ea2bc75c440928c6a1581b0e8b6b32022-12-21T19:28:10ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-11-011210.3389/fimmu.2021.765044765044Pro- and Anti- Effects of Immunoglobulin A- Producing B Cell in Tumors and Its TriggersZiwen Zhong0Ziwen Zhong1Ke Nan2Meilin Weng3Ying Yue4Wenchang Zhou5Zhiqiang Wang6Yiwei Chu7Yiwei Chu8Ronghua Liu9Changhong Miao10Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Anesthesiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, ChinaDepartment of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, ChinaDepartment of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, ChinaShanghai Fifth People’s Hospital and Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, ChinaShanghai Fifth People’s Hospital and Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, ChinaDepartment of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, ChinaB cells are well known as key mediators of humoral immune responses via the production of antibodies. Immunoglobulin A (IgA) is the most abundantly produced antibody isotype and provides the first line of immune protection at mucosal surfaces. However, IgA has long been a divisive molecule with respect to tumor progression. IgA exerts anti- or pro-tumor effect in different tumor types. In this review, we summarize emerging evidence regarding the production and effects of IgA and IgA+ cells in the tumor microenvironment (TME). Moreover, we discuss that the TME cytokines, host diet, microbiome, and metabolites play a pivotal role in controlling the class-switch recombination (CSR) of IgA. The analysis of intratumoral Ig repertoires and determination of metabolites that influence CSR may help establish novel therapeutic targets for the treatment of cancers.https://www.frontiersin.org/articles/10.3389/fimmu.2021.765044/fullB cellsplasma cellsimmunoglobulin Atumor immunityclass switching
spellingShingle Ziwen Zhong
Ziwen Zhong
Ke Nan
Meilin Weng
Ying Yue
Wenchang Zhou
Zhiqiang Wang
Yiwei Chu
Yiwei Chu
Ronghua Liu
Changhong Miao
Pro- and Anti- Effects of Immunoglobulin A- Producing B Cell in Tumors and Its Triggers
Frontiers in Immunology
B cells
plasma cells
immunoglobulin A
tumor immunity
class switching
title Pro- and Anti- Effects of Immunoglobulin A- Producing B Cell in Tumors and Its Triggers
title_full Pro- and Anti- Effects of Immunoglobulin A- Producing B Cell in Tumors and Its Triggers
title_fullStr Pro- and Anti- Effects of Immunoglobulin A- Producing B Cell in Tumors and Its Triggers
title_full_unstemmed Pro- and Anti- Effects of Immunoglobulin A- Producing B Cell in Tumors and Its Triggers
title_short Pro- and Anti- Effects of Immunoglobulin A- Producing B Cell in Tumors and Its Triggers
title_sort pro and anti effects of immunoglobulin a producing b cell in tumors and its triggers
topic B cells
plasma cells
immunoglobulin A
tumor immunity
class switching
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.765044/full
work_keys_str_mv AT ziwenzhong proandantieffectsofimmunoglobulinaproducingbcellintumorsanditstriggers
AT ziwenzhong proandantieffectsofimmunoglobulinaproducingbcellintumorsanditstriggers
AT kenan proandantieffectsofimmunoglobulinaproducingbcellintumorsanditstriggers
AT meilinweng proandantieffectsofimmunoglobulinaproducingbcellintumorsanditstriggers
AT yingyue proandantieffectsofimmunoglobulinaproducingbcellintumorsanditstriggers
AT wenchangzhou proandantieffectsofimmunoglobulinaproducingbcellintumorsanditstriggers
AT zhiqiangwang proandantieffectsofimmunoglobulinaproducingbcellintumorsanditstriggers
AT yiweichu proandantieffectsofimmunoglobulinaproducingbcellintumorsanditstriggers
AT yiweichu proandantieffectsofimmunoglobulinaproducingbcellintumorsanditstriggers
AT ronghualiu proandantieffectsofimmunoglobulinaproducingbcellintumorsanditstriggers
AT changhongmiao proandantieffectsofimmunoglobulinaproducingbcellintumorsanditstriggers